Fitterfly Diabetes CGM Digital Therapeutics Program for Glycemic Control and Weight Management in People With Type 2 Diabetes Mellitus: Real-world Effectiveness Evaluation
Authors:
- Shilpa JoshiSJShilpa Joshi
- Ritika VermaRVRitika Verma
- Tejal LathiaTLTejal Lathia
- Chitra SelvanCSChitra Selvan
- Snehal TannaSTSnehal Tanna
- Amit SarafASAmit Saraf
- Mangesh TiwaskarMangesh Tiwaskar
- Alok ModiAMAlok Modi
- Sanjay KalraSKSanjay Kalra
- Vasudevarao KVKVasudevarao K
- Manoj ChitaleMCManoj Chitale
- Forum MaldeFMForum Malde
Open Access
- 3 May 2023
- journal article
- research article
- Published by JMIR Publications Inc. in JMIR Diabetes
- Vol. 8 (1) , e43292
Abstract
Background: Digital therapeutic platforms facilitate health care through patient-centered strategies based on multidisciplinary teams and shared decision-making. Such platforms can be used for developing a dynamic model of diabetes care delivery, which can help in improving glycemic control by promoting long-term behavior changes in people with diabetes. Objective: This study aims to evaluate the real-world effectiveness of the Fitterfly Diabetes CGM digital therapeutics program for improving glycemic control in people with type 2 diabetes mellitus (T2DM) after the completion of 90 days in the program. Methods: We analyzed deidentified data of 109 participants in the Fitterfly Diabetes CGM program. This program was delivered through the Fitterfly mobile app coupled with continuous glucose monitoring (CGM) technology. This program consists of 3 phases: the first phase is observation, wherein the patient’s CGM readings are observed for 7 days (week 1); the second phase is the intervention; and the third phase aims at sustaining the lifestyle modification introduced during the second phase. The primary outcome of our study was the change in the participants’ hemoglobin A1c (HbA1c) levels after program completion. We also evaluated the changes in participant weight and BMI after the program, changes in the CGM metrics in the initial 2 weeks of the program, and the effects of participant engagement in the program on improving their clinical outcomes. Results: At the end of the 90 days of the program, the mean HbA1c levels, weight, and BMI of the participants were significantly reduced by 1.2% (SD 1.6%), 2.05 (SD 2.84) kg, and 0.74 (SD 1.02) kg/m2 from baseline values of 8.4% (SD 1.7%), 74.45 (SD 14.96) kg, and 27.44 (SD 4.69) kg/m2 in week 1, respectively (P<.001). The average blood glucose levels and time above range values showed a significant mean reduction by 16.44 (SD 32.05) mg/dL and 8.7% (SD 17.1%) in week 2 from week 1 baseline values of 152.90 (SD 51.63) mg/dL and 36.7% (SD 28.4%), respectively (P<.001 for both). Time in range values significantly improved by 7.1% (SD 16.7%) from a baseline value of 57.5% (SD 25%) in week 1 (P<.001). Of all the participants, 46.9% (50/109) showed HbA1c reduction ≥1% and 38.5% (42/109) showed weight loss ≥4%. The average number of times the mobile app was opened by each participant during the program was 108.80 (SD 127.91) times. Conclusions: Our study shows that participants in the Fitterfly Diabetes CGM program showed a significant improvement in their glycemic control and reduction in weight and BMI. They also showed a high level of engagement with the program. Weight reduction was significantly associated with higher participant engagement with the program. Thus, this digital therapeutic program can be considered as an effective tool for improving glycemic control in people with T2DM.Keywords
All Related Versions
This publication has 33 references indexed in Scilit:
- Diabetes Self-management Education and Support in Type 2 Diabetes: A Joint Position Statement of the American Diabetes Association, the American Association of Diabetes Educators, and the Academy of Nutrition and DieteticsClinical Diabetes, 2016
- Personalized Nutrition by Prediction of Glycemic ResponsesCell, 2015
- Impact of Diabetes Mellitus on Hospitalization for Heart Failure, Cardiovascular Events, and DeathCirculation, 2015
- New Approaches to Providing Individualized Diabetes Care in the 21st CenturyCurrent Diabetes Reviews, 2015
- Impact of Visit-to-Visit Glycemic Variability on the Risks of Macrovascular and Microvascular Events and All-Cause Mortality in Type 2 Diabetes: The ADVANCE TrialDiabetes Care, 2014
- Current status of management, control, complications and psychosocial aspects of patients with diabetes in India: Results from the DiabCare India 2011 StudyIndian Journal of Endocrinology and Metabolism, 2014
- A prospective study of prevalence and association of peripheral neuropathy in Indian patients with newly diagnosed type 2 diabetes mellitusJournal of Postgraduate Medicine, 2014
- Barriers and solutions to diabetes management: An Indian perspectiveIndian Journal of Endocrinology and Metabolism, 2013
- Implementation of a Diabetes Self-management Education Program in Primary Care for Adults Using Shared Medical AppointmentsThe Diabetes Educator, 2011
- Consensus statement for diagnosis of obesity, abdominal obesity and the metabolic syndrome for Asian Indians and recommendations for physical activity, medical and surgical management.2009